GraniteShares 2x Long NVDA Daily ETF vs Koninklijke Philips NV — how do they compare? GraniteShares 2x Long NVDA Daily ETF trades at $36.86 (market cap $3.56B), while Koninklijke Philips NV trades at $24.24 (market cap $23.52B). The key difference: Koninklijke Philips NV is far larger — about 6.6× GraniteShares 2x Long NVDA Daily ETF's market cap, and Koninklijke Philips NV pays a 4.17% dividend while GraniteShares 2x Long NVDA Daily ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold GraniteShares 2x Long NVDA Daily ETF for 15 Days and Koninklijke Philips NV for 84 Days on average.
| NVDL | PHG | |
|---|---|---|
Market Cap | $3.56B | $23.52B |
Volume | 9,740,643 | 1,635,069 |
Sector | Leveraged / Inverse | Health |
52-Week High | $43.02 | $32.91 |
52-Week Low | $21.76 | $23.81 |
Typical Hold Time | 15 Days | 84 Days |
Enterprise Value | — | $29.87B |
Dividend Yield | — | 4.17% |
Signals from Pluang's Aura AI — not financial advice
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $37.28, down 5.79% in the last session. Technical indicators show a bullish overall signal with moving averages supporting upside momentum while oscillators remain neutral. The ETF tracks Nvidia's performance with 2x daily leverage, benefiting from Nvidia's strong AI leadership and consistent earnings beats. Recent news highlights Nvidia's continued dominance in AI chips and the ETF's leveraged exposure to this growth story.
The outlook remains positive given Nvidia's AI market leadership and technical breakout potential, though leveraged ETF structure introduces volatility decay risks. Key support sits at $36 with resistance at $39-41. Investors should monitor Nvidia's earnings performance and broader AI sector trends for directional cues.
PHG trades at $24.30, up 0.87% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong cash flow generation. Recent news highlights product innovations including new CT systems and AI healthcare advancements, while institutional ownership shows mixed activity.
The outlook remains cautious with analyst consensus at Hold (63.64%) despite positive earnings momentum. Key risks include cybersecurity threats and competitive pressures in health technology. The stock presents a recovery opportunity but requires monitoring of execution risks and market sentiment shifts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →